Weight decreased and Injection site extravasation

Summary:

Injection site extravasation is found among people with Weight decreased, especially for people who are female, 50-59 old.

The study analyzes which people have Injection site extravasation with Weight decreased. It is created by eHealthMe based on reports of 63 people who have Weight decreased from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Weight decreased?

Weight decreased is found to be associated with 3,385 drugs and 4,751 conditions by eHealthMe. Check the latest studies of Weight decreased.

What is Injection site extravasation?

Injection site extravasation (flow of (blood or lymph) from injection site) is found to be associated with 555 drugs and 728 conditions by eHealthMe. Check the latest studies of Injection site extravasation.

On Jul, 27, 2026

63 people who have Weight Decreased and Injection Site Extravasation are studied.

Would you have Injection site extravasation when you have Weight decreased?

Gender of people who have Weight Decreased and experienced Injection Site Extravasation *:

female: 79.37 %
male: 20.63 %

Age of people who have Weight Decreased and experienced Injection Site Extravasation *:

Common co-existing conditions for these people *:

Type 2 Diabetes: 14 people, 22.22%
Diabetes: 6 people, 9.52%
Stress And Anxiety: 4 people, 6.35%
Hypersensitivity: 4 people, 6.35%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 4 people, 6.35%
High Blood Pressure: 4 people, 6.35%
Back Pain: 4 people, 6.35%
Back Disorder: 3 people, 4.76%
Depression: 3 people, 4.76%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 4.76%

Common drugs taken by these people *:

Common symptoms for these people *:

Injection Site Haemorrhage (bleeding from injection site): 15 people, 23.81%
Injection Site Pain: 15 people, 23.81%
Nausea (feeling of having an urge to vomit): 6 people, 9.52%
Weakness: 5 people, 7.94%
Injection Site Bruising: 4 people, 6.35%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 4.76%
Headache (pain in head): 3 people, 4.76%
Injection Site Mass: 3 people, 4.76%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 3.17%
Injection Site Erythema (redness at injection site): 2 people, 3.17%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Injection site extravasation?

- Check whether Injection site extravasation is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Injection site extravasation and Weight decreased, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.